Cargando…
Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside
Coronavirus disease 2019 (Covid-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is primarily regarded as a respiratory disease; however, multisystemic involvement accompanied by a variety of clinical manifestations, including neurological symptoms, are commonly o...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361071/ https://www.ncbi.nlm.nih.gov/pubmed/36208899 http://dx.doi.org/10.1016/bs.irn.2022.06.006 |
_version_ | 1784764452033265664 |
---|---|
author | Emmi, Aron Boura, Iro Raeder, Vanessa Mathew, Donna Sulzer, David Goldman, James E. Leta, Valentina |
author_facet | Emmi, Aron Boura, Iro Raeder, Vanessa Mathew, Donna Sulzer, David Goldman, James E. Leta, Valentina |
author_sort | Emmi, Aron |
collection | PubMed |
description | Coronavirus disease 2019 (Covid-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is primarily regarded as a respiratory disease; however, multisystemic involvement accompanied by a variety of clinical manifestations, including neurological symptoms, are commonly observed. There is, however, little evidence supporting SARS-CoV-2 infection of central nervous system cells, and neurological symptoms for the most part appear to be due to damage mediated by hypoxic/ischemic and/or inflammatory insults. In this chapter, we report evidence on candidate neuropathological mechanisms underlying neurological manifestations in Covid-19, suggesting that while there is mostly evidence against SARS-CoV-2 entry into brain parenchymal cells as a mechanism that may trigger Parkinson's disease and parkinsonism, that there are multiple means by which the virus may cause neurological symptoms. |
format | Online Article Text |
id | pubmed-9361071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93610712022-08-09 Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside Emmi, Aron Boura, Iro Raeder, Vanessa Mathew, Donna Sulzer, David Goldman, James E. Leta, Valentina Int Rev Neurobiol Article Coronavirus disease 2019 (Covid-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is primarily regarded as a respiratory disease; however, multisystemic involvement accompanied by a variety of clinical manifestations, including neurological symptoms, are commonly observed. There is, however, little evidence supporting SARS-CoV-2 infection of central nervous system cells, and neurological symptoms for the most part appear to be due to damage mediated by hypoxic/ischemic and/or inflammatory insults. In this chapter, we report evidence on candidate neuropathological mechanisms underlying neurological manifestations in Covid-19, suggesting that while there is mostly evidence against SARS-CoV-2 entry into brain parenchymal cells as a mechanism that may trigger Parkinson's disease and parkinsonism, that there are multiple means by which the virus may cause neurological symptoms. Elsevier Inc. 2022 2022-08-09 /pmc/articles/PMC9361071/ /pubmed/36208899 http://dx.doi.org/10.1016/bs.irn.2022.06.006 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Emmi, Aron Boura, Iro Raeder, Vanessa Mathew, Donna Sulzer, David Goldman, James E. Leta, Valentina Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside |
title | Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside |
title_full | Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside |
title_fullStr | Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside |
title_full_unstemmed | Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside |
title_short | Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside |
title_sort | covid-19, nervous system pathology, and parkinson's disease: bench to bedside |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361071/ https://www.ncbi.nlm.nih.gov/pubmed/36208899 http://dx.doi.org/10.1016/bs.irn.2022.06.006 |
work_keys_str_mv | AT emmiaron covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside AT bourairo covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside AT raedervanessa covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside AT mathewdonna covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside AT sulzerdavid covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside AT goldmanjamese covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside AT letavalentina covid19nervoussystempathologyandparkinsonsdiseasebenchtobedside |